(Source: WIPO)
From the newsletter
African vaccine production has seen a major milestone in the pursuit of local manufacturing capacity. Cape Town-based Biovac Institute is now capable of completing the entire vaccine manufacturing process on its own. This supports climate-health responses and will over time reduce vaccine imports, which currently stand at over 70%.
The institute joins a handful of manufacturers in Africa with a product development laboratory that can see vaccines through from early-stage research to final formulation.
The manufacturing of a vaccine has at least six stages, which in most cases is done by different manufacturing companies in collaboration either through technology transfer or assisted licensing.
More details